Patents by Inventor Davide Panighetti

Davide Panighetti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12558432
    Abstract: The present disclosure relates to the delivery of multiple copies of a payload molecule such as an active agent or a chelating agent capable of capturing an active agent, using as a carrier for their delivery a biocompatible copolymer comprising side chain-linked amino acids functionalized at their alpha-amino group by a reactive azide moiety by means of which the payload molecules are coupled to the copolymer. The copolymer is typically further functionalized to contain a single copy of a cell type- or tissue type-specific targeting moiety.
    Type: Grant
    Filed: October 30, 2020
    Date of Patent: February 24, 2026
    Assignee: CIS BIOPHARMA AG
    Inventors: Christian Geraths, Christophe Thommen, Michael Hackebeil, Davide Panighetti, Hans Hitz
  • Publication number: 20220409737
    Abstract: The present disclosure relates to the delivery of multiple copies of a payload molecule such as an active agent or a chelating agent capable of capturing an active agent, using as a carrier for their delivery a biocompatible copolymer comprising side chain-linked amino acids functionalized at their alpha-amino group by a reactive azide moiety by means of which the payload molecules are coupled to the copolymer. The copolymer is typically further functionalized to contain a single copy of a cell type- or tissue type-specific targeting moiety.
    Type: Application
    Filed: October 30, 2020
    Publication date: December 29, 2022
    Inventors: Christian GERATHS, Christophe THOMMEN, Michael HACKEBEIL, Davide PANIGHETTI, Hans HITZ
  • Publication number: 20210128735
    Abstract: The present disclosure relates to the delivery of active agents, e.g., drug substances, using as carriers for their delivery biocompatible copolymers comprising side chain-linked amino acids having active agents bound to their alpha-amino and/or alpha-carboxyl groups, either directly or via linker molecules. The active agent-containing copolymers can be functionalized to contain cell type- or tissue type-specific targeting moieties.
    Type: Application
    Filed: May 8, 2019
    Publication date: May 6, 2021
    Inventors: Christian Geraths, Christophe Thommen, Michael Hackebeil, Davide Panighetti, Hans Hitz